
CPHI & PMEC China 2026
06/2026 – 06/2026
Shandong Jincheng Pharmaceutical Group Co., Ltd. (stock code SZ300233), established in 2004, is a pharmaceutical and health industry group whose main business spans pharmaceutical intermediates, APIs and finished dosage forms, integrating R&D, production and sales. The company holds several well-known brand products in the market, including Jincheng Cephalosporin Intermediate, Golden Quality Antibiotic Series, Lang'yi Gynecology Series, Jin'Wa'Ning Pediatric Series and Glutathione Health Products.

No comments available.
Leave your rating & comment